Millions given access to breast, cervical cancer screening: CDC

August 7, 2014
Millions given access to breast, cervical cancer screening: CDC
Report details success of CDC program for women with limited health care access.

(HealthDay)—Millions of American women have benefited from a breast and cervical cancer screening program offered by the U.S. Centers for Disease Control and Prevention, according to a new report.

The program was launched in 1991 to serve women with limited access to health care. It has provided screening for more than 4 million women in its first 20 years. During that time, the program identified more than 56,000 breast cancers, approximately 3,200 cervical cancers, and over 152,000 .

In more than 90 percent of these cases, women received proper and timely follow-up care, according to the CDC report.

The estimated cost of the was $145 per woman.

"Today, millions of women have benefited from the timely screening and diagnostic services offered by CDC's National Breast and Cervical Cancer Early Detection Program," Ursula Bauer, director of the CDC's National Center for Chronic Disease Prevention and Health Promotion, said in an agency news release.

"This program has made tremendous contributions in public health through strengthening partnerships, health care collaborations, and quality of care, but also at a personal level by serving women directly," she added.

The report was published online and in an Aug. 15 supplement edition of the journal Cancer. The report features 13 new studies evaluating numerous features of the screening program.

Explore further: Cervical cancer prevention program saves lives

More information: The U.S. National Cancer Institute has more about breast cancer screening.

Related Stories

Cervical cancer prevention program saves lives

July 16, 2014
A 23-year old federal program for the early detection and treatment of cervical cancer markedly reduces illness and death among underserved, low-income women, yet its impact has been reduced by the fact that it has reached ...

More than a million women could gain access to potentially life saving tests for cancer

November 15, 2012
A study by researchers at the George Washington University School of Public Health and Health Services (SPHHS) indicates that full implementation of the Affordable Care Act would expand health insurance coverage for more ...

A negative HPV test may predict lower cervical cancer risk than a negative Pap

July 19, 2014
In the US, cotesting for human papilloma virus (HPV) and Pap testing for cervical cancer every 5 years for women aged 30-65 years is now recommended. However, HPV testing alone may provide better reassurance against cervical ...

Women's cancer screenings down during great recession

March 27, 2014
(Medical Xpress)—American women were less likely to receive a mammogram or Pap smear during the Great Recession of 2007-2009 than they were five years earlier, according to a study by researchers at the University of Maryland ...

What's the best test for cervical cancer? Pap, HPV or both?

June 9, 2014
Should U.S. women be screened for cervical cancer with Pap tests, HPV tests or both? According to researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) while the merits of screening ...

Radiation therapy for cervical cancer increases risk for colorectal cancer

April 17, 2014
Researchers at the University of Texas Medical Branch at Galveston are the first to recommend that young women treated with radiation for cervical cancer should begin colorectal cancer screening earlier than traditionally ...

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.